Acquisition of American Medical Systems urology portfolio

Boston Scientific Corporation
2014 - 2015

Our attorneys represented Boston Scientific Corporation in its acquisition of American Medical Systems’ urology portfolio from Endo for US$1.6 billion.  The transaction required filings in the US, Spain, Germany, and Colombia.  As stated by Mike Mahoney, President and CEO of Boston Scientific, “The combination of Boston Scientific's Urology and Women's Health and AMS' urology portfolios will create a business with nearly $1 billion in annual sales and enable significant synergies and strong future growth prospects through portfolio innovation and international market expansion.”

Email Disclaimer